Company
Specific Biologics
Advancing industry-leading Dualase genome editors as transformative medicines
Also known as Specific Biologics Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Specific Biologics Inc
Claim, correct or request removal
Record updated 29 September 2026
About
A differentiated genome editing platform delivering predictable and efficient edits with undetectable off-target effects and plug-and-play programmability for broad in vivo therapeutic applications
Funding snapshot
- Latest round
- Grant2026-03-18
Funding rounds
- Grant
- 2026-03-18
- Seed
- 2021-12-16
Loading relationship preview